Phase 4 N=20 Study of the Effectiveness of Ozurdex for the Control of Uveitis
Uveitis, Intermediate · Uveitis, Posterior
Primary: Number of Participants With Absence of Intraocular Inflammation at 6 Months — 12 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=79 Gait Modification Treatment for Knee Osteoarthritis
Knee Osteoarthritis
Primary: Change From Baseline to Week 17 and From Baseline to Week 21 in Pain as Measured by Numerical Rating Scale — -2.1; -1.8; -2.2; -1.5 units on a scale — p=0.495
N/A N=27 Effect of Balloon Cryoablation on Left Atrial Function
Atrial Fibrillation
Primary: Number of Participants With Acute Procedural Success (APS) — 27 Participants
Phase 4 N=47 A Study of L-DOPA for Depression and Slowing in Older Adults
Major Depressive Disorder · Dysthymia · Depression Not Otherwise Specified
Primary: Hamilton Rating Scale for Depression (24 Item) — 10.94 Units on a Scale
N/A N=72 Does Treating Anxiety Symptoms With ACT Improve Vascular Inflammation and Function?
Anxiety
Primary: Beck Anxiety Inventory (BAI) — 18.750; 17.464; 13.317; 16.154 score on a scale — p=0.02
Phase 1 N=48 A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)
Postmenopausal · Osteopenia
Primary: Number of Participants With Adverse Events — 10; 6; 6; 6 Participants
Phase 4 N=184 Predictors of Response to Iron and Erythropoietin Stimulating Agents
Renal Failure Chronic · Anemia
Primary: Hemoglobin Incrementation — 61; 53 Participants
Phase 1 N=48 AMG 529 First in Human Study
Cardiovascular
Primary: Number of Participants With Adverse Events (AEs) — 3; 0; 0; 2 Participants
Phase 2 N=37 Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
Head and Neck Cancer
Primary: Progression Free Survival (PFS) — 60 percentage of participants
N/A N=97 A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block
Upper Extremity Surgery
Primary: Duration of the Sensorial Supraclavicular Block — 13.4; 14; 17.4; 18.8 hour
Phase 3 N=67 A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis
Postmenopausal Osteoporosis
Primary: Percent Change From Baseline to Month 6 in Bone Mineral Density at the Lumbar Spine — -0.1; 9.5 percent change — p=<0.001
N/A N=14 The Sensorimotor Locus of Balance Control in Elderly Gait
Ambulation Difficulty · Gait, Unsteady · Fall
Primary: Change in Postural Sway After 10 Min of Walking — -2.39; -0.01 cm
Phase 1 N=74 A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women
Osteopenia
Primary: Number of Participants With Adverse Events — 9; 4; 4; 1 Participants
N/A N=70 Helping Empower Liver and Kidney Patients
Hepatitis C · Chronic Kidney Diseases · Patient Education
Primary: Change in Knowledge — 53.54; 65.74 percentage of correct responses — p=<0.001
N/A N=1,144 Involving Men in Maternity Care in Burkina Faso
Postpartum Period
Primary: Number of Participants Attending the Recommended Number of Postnatal Care Appointments — 342; 265 Participants